Causes of Death Among Patients Supported by Extracorporeal Membrane Oxygenation

Renata P. Lerner MD, PhD , Amira Mohamed MD , Annette Ilg MD , Raghu R. Seethala MD , Alison Witkin MD , Jerome Crowley MD , Anthony Carlese MD , Michelle Ng Gong MD, MPH , Iris Aimlin MD , Jen-Ting Chen MD, MS , David Furfaro MD, MPH , Brian O’Gara MD , Ryan Gardner MD , Malorie Butera RN , Shahzad Shaefi MD, MPH , Daniel Knox MD , Daniel Gutteridge MD, MBA , Christie Horner BSN, CCRN , Anthony Manasia MD, MPH , Nidhi Kavi MD , Ari Moskowitz MD, MPH
{"title":"Causes of Death Among Patients Supported by Extracorporeal Membrane Oxygenation","authors":"Renata P. Lerner MD, PhD ,&nbsp;Amira Mohamed MD ,&nbsp;Annette Ilg MD ,&nbsp;Raghu R. Seethala MD ,&nbsp;Alison Witkin MD ,&nbsp;Jerome Crowley MD ,&nbsp;Anthony Carlese MD ,&nbsp;Michelle Ng Gong MD, MPH ,&nbsp;Iris Aimlin MD ,&nbsp;Jen-Ting Chen MD, MS ,&nbsp;David Furfaro MD, MPH ,&nbsp;Brian O’Gara MD ,&nbsp;Ryan Gardner MD ,&nbsp;Malorie Butera RN ,&nbsp;Shahzad Shaefi MD, MPH ,&nbsp;Daniel Knox MD ,&nbsp;Daniel Gutteridge MD, MBA ,&nbsp;Christie Horner BSN, CCRN ,&nbsp;Anthony Manasia MD, MPH ,&nbsp;Nidhi Kavi MD ,&nbsp;Ari Moskowitz MD, MPH","doi":"10.1016/j.chstcc.2024.100114","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Mortality for patients who are critically ill receiving extracorporeal membrane oxygenation (ECMO) support (venovenous or venoarterial) is high, but the proximal causes of death have not been characterized fully.</div></div><div><h3>Research Question</h3><div>We aimed to characterize the reasons for death in patients who underwent cannulation while receiving venoarterial or venovenous ECMO.</div></div><div><h3>Study Design and Methods</h3><div>This was a retrospective multicenter observational cohort study of adult patients who underwent cannulation for ECMO and who died while receiving ECMO at 6 medical centers in the United States.</div></div><div><h3>Results</h3><div>We categorized the causes of death for 751 patients who underwent cannulation for ECMO. We summarized and compared baseline patient characteristics among the 6 sites. Reasons for death were comorbid withdrawal of life-sustaining therapy (n = 248 [33%]), progressive hemodynamic shock (n = 200 [27%]), neurologic withdrawal of life-sustaining therapy (n = 135 [18%]), cardiogenic shock (n = 126 [17%]), respiratory failure (n = 31 [4.1%]), and equipment failure (n = 11 [1.5%]). Comorbid withdrawal of life-sustaining therapy was the most common cause of death in patients who underwent cannulation for both venoarterial (n = 141 [29%]) and venovenous (n = 107 [41%]) ECMO. The rate of palliative care consultation differed among sites.</div></div><div><h3>Interpretation</h3><div>This study showed that most deaths result from comorbid withdrawal of life-sustaining therapy and that death or withdrawal because of refractory respiratory failure and cardiogenic shock account for a lower proportion of deaths in patients receiving ECMO. Our efforts to reduce mortality in patients receiving ECMO should account for the proportion of deaths attributable to comorbid withdrawal of life-sustaining therapy.</div></div>","PeriodicalId":93934,"journal":{"name":"CHEST critical care","volume":"3 1","pages":"Article 100114"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHEST critical care","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949788424000686","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Mortality for patients who are critically ill receiving extracorporeal membrane oxygenation (ECMO) support (venovenous or venoarterial) is high, but the proximal causes of death have not been characterized fully.

Research Question

We aimed to characterize the reasons for death in patients who underwent cannulation while receiving venoarterial or venovenous ECMO.

Study Design and Methods

This was a retrospective multicenter observational cohort study of adult patients who underwent cannulation for ECMO and who died while receiving ECMO at 6 medical centers in the United States.

Results

We categorized the causes of death for 751 patients who underwent cannulation for ECMO. We summarized and compared baseline patient characteristics among the 6 sites. Reasons for death were comorbid withdrawal of life-sustaining therapy (n = 248 [33%]), progressive hemodynamic shock (n = 200 [27%]), neurologic withdrawal of life-sustaining therapy (n = 135 [18%]), cardiogenic shock (n = 126 [17%]), respiratory failure (n = 31 [4.1%]), and equipment failure (n = 11 [1.5%]). Comorbid withdrawal of life-sustaining therapy was the most common cause of death in patients who underwent cannulation for both venoarterial (n = 141 [29%]) and venovenous (n = 107 [41%]) ECMO. The rate of palliative care consultation differed among sites.

Interpretation

This study showed that most deaths result from comorbid withdrawal of life-sustaining therapy and that death or withdrawal because of refractory respiratory failure and cardiogenic shock account for a lower proportion of deaths in patients receiving ECMO. Our efforts to reduce mortality in patients receiving ECMO should account for the proportion of deaths attributable to comorbid withdrawal of life-sustaining therapy.
体外膜氧合患者的死亡原因
研究背景接受体外膜肺氧合(ECMO)支持(静脉或静脉动脉)的重症患者死亡率很高,但死亡的近因尚未完全确定。研究问题我们旨在确定接受静脉动脉或静脉 ECMO 时接受插管的患者的死亡原因。研究设计和方法这是一项回顾性多中心观察队列研究,研究对象是在美国 6 家医疗中心接受插管 ECMO 并在接受 ECMO 期间死亡的成年患者。我们总结并比较了 6 家医疗中心的患者基线特征。死亡原因包括合并症撤消维持生命疗法(248 人 [33%])、进行性血流动力学休克(200 人 [27%])、神经系统撤消维持生命疗法(135 人 [18%])、心源性休克(126 人 [17%])、呼吸衰竭(31 人 [4.1%])和设备故障(11 人 [1.5%])。在接受静脉动脉插管(n = 141 [29%])和静脉静脉插管(n = 107 [41%])ECMO 的患者中,最常见的死亡原因是合并撤消维持生命疗法。这项研究表明,大多数死亡病例是由于合并症撤除维持生命疗法所致,而在接受 ECMO 的患者中,因难治性呼吸衰竭和心源性休克而死亡或撤除维持生命疗法的比例较低。我们在努力降低接受 ECMO 患者的死亡率时,应考虑到因合并症停用维持生命疗法而导致的死亡比例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CHEST critical care
CHEST critical care Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信